Apogem Capital LLC Vertex Pharmaceuticals Inc Transaction History

Apogem Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$177.01 - $223.45 $210,641 - $265,905	-1,190 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $164,157 - $183,705	-905 Reduced 43.2%	1,190 $216,000
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $158,054 - $186,387	-843 Reduced 28.69%	2,095 $422,000
Q1 2021 May 14, 2021	BUY	$207.02 - $241.31 $237,244 - $276,541	1,146 Added 63.95%	2,938 $631,000
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $370,961 - $494,753	1,792 New	1,792 $424,000

1,724

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $119B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Apogem Capital LLC with notifications on news.